AtaiBeckley (ATAI) Acquisitions (2021)
AtaiBeckley's (ATAI) quarterly Acquisitions came in at $37000.0 in Q2 2021, up 270.0% quarter-over-quarter from $10000.0 in Q1 2021.
AtaiBeckley (ATAI) Acquisitions (2021) Analysis & Trends
AtaiBeckley has disclosed Acquisitions across 1 years of filings, most recently posting $37000.0 for Q2 2021.
- Acquisitions for Q2 2021 came in at $37000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $37000.0 (changed N/A YoY), and the FY2024 annual result was $359000.0, changed N/A from the prior year.
- Acquisitions came in at $37000.0 for Q2 2021 at AtaiBeckley, up from $10000.0 in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $37000.0 in Q2 2021 to a low of $10000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 37,000.00 |
| Mar 31, 2021 | 10,000.00 |